Optimis Fusion

In this page

3 reasons to choose Optimis Fusion™
Technological advantages of Optimis Fusion™
Take full advantage with a wide range of accessories
Want to know more?

CATARACT AND GLAUCOMA LASER PLATFORM

Optimis Fusion™ is a versatile laser platform combining YAG photodisruption treatments and advanced SLT photoregeneration therapy in one fully integrated system.

Upgradable, it can easily be transformed into a trio, anterior and posterior laser treatment platform by combing it with a compatible Quantel Medical retina laser.

Key Features

Premium optics for viewing both the anterior and posterior segments.
Quantel Medical proprietary technology: dual-mode YAG/SLT laser cavity.

3 reasons to choose Optimis Fusion™

Premium Optics

Built into a premium Zeiss type slit lamp, Optimis Fusion™ provides a superior vision of both the anterior and posterior chambers.

It features an LED illumination source providing a sharp, bright and homogeneous illumination.

Advanced technology

Dual-mode YAG / SLT laser cavity, optimized to produce 1064nm and 532nm nanosecond pulses from one laser cavity.

Powerful, precise and efficient Nd:YAG Laser / Full-featured SLT laser.

Easy switch from YAG to SLT mode, easy to use software.

Fully integrated glaucoma
and cataract laser platform

Optimis Fusion™ easily combines with Quantel Medical's Vitra 2 Monospot or MultiSpot Pattern Scanning photocoagulators, offering a YAG, SLT and MultiSpot Pattern Scanning Retina Laser platform all-in-one.

Technological advantages of Optimis Fusion™

Precise and Powerful

Optimis Fusion™ YAG laser delivers high-performance photodisruption for capsulotomy and peripheral iridotomy. Its gaussian laser beam profile allows for precise delivery, only requiring minimum energy levels, which avoids side effects such as lens pitting.

Precise tissue targeting is achieved with the advanced two-point aiming beam, allowing for fast and accurate targeting of the capsule; and the adjustable offset feature allows for easy focus adjustment behind or at the point of disruption.

SLT Laser Therapy

First-line treatment. No thermal Damage. Repeatable.

Selective Laser Trabeculoplasty (SLT) is a proven therapy supported by more than 10 years of clinical data. SLT targets melanin-rich cells which absorb the laser energy to induce a healing response that begins to restore the function of the trabecular meshwork.

The laser energy is delivered in short, fixed pulses over a large, homogeneous spot size, resulting in no thermal damage. Due to the gentle delivery and no permanent destruction to the trabecular meshwork, SLT leaves the structures intact and can be repeated if necessary.

LEARN MORE

Take full advantage
with a wide range of accessories

Want to know more?

WANT TO KNOW MORE
ABOUT GLAUCOMA LASER ASSISTED SOLUTIONS (GLASS)?

Discover our micro-website dedicated to laser therapies for each glaucoma stage.

As a world leader in lasers in Ophthalmology, Lumibird Medical offers a comprehensive approach to Glaucoma Laser Therapy with treatment options at every stage of the disease paradigm: SLT for early glaucoma treatment, SubCyclo for advanced glaucoma treatment and ThermoCyclo for last resort treatment.

Lue lisää

WANT TO DEMO OPTIMIS FUSION™?

Lumibird Medical participates in many events throughout the year.

Find in our Events section the next congresses in which we will participate and come, visit us on our booth to test our products!

Lue lisää

SLT: A Comprehensive Treatment S...

15/03/2024

A highly effective approach for first-line glaucoma treatment, as adjunct therapy with drugs, and as alternative therapy w...

The duality of SLT in glaucoma m...

15/03/2024

Selective laser trabeculoplasty (SLT) has been employed as a safe and effective means for lowering intraocular pressure (I...

Download brochure

The information collected through this form is recorded and transmitted to the relevant LUMIBIRD MEDICAL departments and enables us to send you any reply to a request via the contact form. The legal basis for the processing is consent. The data collected are kept for 3 years in digital format and are only transmitted to LUMIBIRD MEDICAL’s internal departments as well as to our distributors and subsidiaries. You have a right to access, rectify, contest, limit the processing of and erase data. For more information on the use of your data and your rights resulting from the amended French Data Protection Act and the GDPR, please consult our data protection policy or contact our Data Protection Officer at privacy@lumibird.com.

I agree to my personal data being used by LUMIBIRD MEDICAL to send me marketing information about LUMIBIRD MEDIACL's new products, events or offers (mailings)

For more informations on how Lumibird Medical uses your data, please see our Terms and conditions.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.